Novartis Investigative Site is a clinical research site located in Orlando, Florida, United States 32806.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 67 clinical trials.
Therapeutic areas: Major Depressive Disorder, Renal Insufficiency, Non-alcoholic Steatohepatitis NASH.
Sponsors: Novartis, Novartis Pharmaceuticals, Debiopharm International SA.
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 67 clinical trials on record. Their work covers Major Depressive Disorder, Renal Insufficiency, Non-alcoholic Steatohepatitis NASH.
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.